Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
about
Heterogeneous Effects of Direct Hypoxia Pathway Activation in Kidney CancerA pilot study using next-generation sequencing in advanced cancers: feasibility and challengesmiRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancerInferring clonal composition from multiple sections of a breast cancerSingle-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancerEpigenetic field defects in progression to cancerCancer genome landscapesDecoding tumour phenotype by noninvasive imaging using a quantitative radiomics approachHigh incidence of somatic BAP1 alterations in sporadic malignant mesotheliomaEstrogen receptor alpha gene amplification in breast cancer: 25 years of debateFalse Discovery Rates in PET and CT Studies with Texture Features: A Systematic ReviewCancer pharmacogenomics: strategies and challengesThe histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSĪ±Intratumor heterogeneity: evolution through space and timeMetabolism of kidney cancer: from the lab to clinical practiceGenetic Heterogeneity and Clonal Evolution of Tumor Cells and their Impact on Precision Cancer MedicineState of the science: an update on renal cell carcinomaPD-L1 expression in human cancers and its association with clinical outcomesOptimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccinesNeoantigen-based cancer immunotherapyThe Role of Genomic Profiling in Advanced Breast Cancer: The Two Faces of JanusCancer pharmacogenomics, challenges in implementation, and patient-focused perspectivesSequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspectiveTumor Heterogeneity in Hepatocellular Carcinoma: Facing the ChallengesSingle-Cell Sequencing Technology in Oncology: Applications for Clinical Therapies and ResearchClinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor CellsCirculating biomarkers to monitor cancer progression and treatmentCirculating tumor DNA: a promising biomarker in the liquid biopsy of cancerConfronting the Care Delivery Challenges Arising from Precision MedicineMolecular Subtypes and Personalized Therapy in Metastatic Colorectal CancerCirculating tumor DNA in hepatocellular carcinoma: trends and challengesCell-free circulating tumor DNA in cancerGenetic profiling of intrahepatic cholangiocarcinoma and its clinical implication in targeted therapyCurrent Insights into Long Non-Coding RNAs in Renal Cell CarcinomaPrecision Medicine and Non-Colorectal Cancer Liver Metastases: Fiction or Reality?Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell VaccinationEvaluation and consequences of heterogeneity in the circulating tumor cell compartmentTumour Cell HeterogeneityTranslational Bioinformatics: Past, Present, and FutureEpigenetic modulators, modifiers and mediators in cancer aetiology and progression
P2860
Q21090542-13A7F5CA-9201-4A60-B84C-D1636EB74B82Q21132483-FF97ACD8-0741-40E6-9541-439488737510Q21133750-8AE00AD0-B5EA-40E2-86E6-7F87110A83AEQ21145293-427669EE-0457-49AD-A428-0902D15D8A65Q22001096-5C61D3FB-96A4-4415-BD37-C8F744D46C5AQ22241089-0A8AC784-00D4-41D3-972C-D7D22F4A8282Q22242276-9C5AE3FF-E738-4BE7-A3A5-B88C722A40FEQ23760721-CAA2B62E-676E-4DB5-8B6D-B9481C40B786Q24170431-8E018FF7-5C8D-4C0E-A2BF-BF86982ECF83Q24273274-CFDC6F41-BA7D-4202-81AA-23DF95DE6759Q24288664-254541E9-7F55-433A-B667-7D5D2485EDB9Q24289309-F80E98D0-5606-450B-8691-A81842959F71Q24339204-008794BA-56EF-4976-B314-243D4D179FD9Q24598678-5C88E71E-65E3-4E8D-80ED-76809B64EC2FQ24600512-1C1E5149-5B8A-4CA3-9DB4-94DE97108BABQ24604479-E823CA04-BFDD-481E-87CA-6782AF2B609FQ24630685-37DE503F-7860-4D1E-8790-CC65AAFA3044Q26738361-83D1BA1A-A98A-48ED-A3E3-A20A0C96CA99Q26738680-61FF8F3B-A349-4E72-B0AF-D7E779F2F1B1Q26738693-63930286-7718-4C02-9E10-06549815F0ECQ26740184-78598F68-6FED-4D15-BDCD-EB388383E7B2Q26741009-3699889C-E614-40A2-A3D0-4772968BE7DDQ26744089-BC14E61F-A2ED-4730-9929-17CE6BEC0E3FQ26744100-48C9283E-FDAE-4E8E-984F-AD92857FCE69Q26744582-0C5A6032-8F4E-4C1A-A83B-717D496EE063Q26744828-82A27998-4BA2-4759-B4D5-D427A5055D6AQ26745985-C5C8C8B4-A8C3-443A-B434-47CE7E3E50E8Q26746010-732C51C9-2294-4DF2-8E92-36F06CD50FFBQ26747282-BC603D75-8960-4079-A034-BB25DBEADAF0Q26747329-B6B647AA-309E-48F5-9710-CFC10D7B5D0AQ26749417-06C4F06F-164A-4FA1-874C-06BBA6658BB7Q26750899-8D346D02-E942-499E-BA75-EBFE25835DB6Q26751655-7574273D-AF3D-4BE9-8B18-B72F61720A0EQ26752381-7F5D9CD6-807C-4231-9C8C-FD88D301E906Q26764984-04207B6F-DAC6-4921-B271-5317DC3AFFF6Q26765345-FE808AEA-E601-4370-B25C-A472FA63D4BCQ26765357-8A8C5B92-D3D1-494B-AA3E-394637084134Q26765895-A63C6026-845A-4109-B211-ABB972EB0D81Q26766146-B869D799-275B-4EE9-802C-5E7268A05DC5Q26766149-0C08CAD9-8A27-43FF-AD69-0DCB915C9EF1
P2860
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
description
2012 nĆ® lÅ«n-bĆ»n
@nan
2012 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« ÕÕ”ÖÕæÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2012 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ“Õ”ÖÕæÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2012幓ć®č«ę
@ja
2012幓č«ę
@yue
2012幓č«ę
@zh-hant
2012幓č«ę
@zh-hk
2012幓č«ę
@zh-mo
2012幓č«ę
@zh-tw
2012幓č®ŗę
@wuu
name
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
@ast
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
@en
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
@nl
type
label
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
@ast
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
@en
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
@nl
prefLabel
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
@ast
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
@en
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
@en
P2093
Adam Butler
Aengus Stewart
Andrew J Rowan
Benjamin Phillimore
Claudio R Santos
David Endesfelder
David Jones
Graham Clark
James Larkin
Lisa Pickering
P2860
P304
P3181
P356
10.1056/NEJMOA1113205
P407
P50
P5008
P577
2012-03-08T00:00:00Z